Azem Chami
Pain Medicine · Shreveport, LANPI 1073066247
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (58.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 64.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $5,115 and has fallen 88.9% since, to $569 in 2025.
Across 103 payments — averaging $83.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Boston Scientific$2K
- Abbott$466
- Saluda Medical Americas, Inc.$314
- Curonix LLC$214
- Averitas Pharma Inc.$59
- plus $115 from 6 others
What the payments were for
- Grants$5,00058%
- Travel & lodging$4105%
- Food & beverage$3,17337%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 10 | $5,502 |
| Boston Scientific | 38 | $1,913 |
| Abbott | 35 | $466 |
| Saluda Medical Americas, Inc. | 10 | $314 |
| Curonix LLC | 2 | $214 |
| Averitas Pharma Inc. | 2 | $59 |
| Scilex Pharmaceuticals Inc. | 1 | $23 |
| Avanos Medical | 1 | $21 |
| Fisher & Paykel Healthcare Inc | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Vertex | 1 | $17 |
| Nevro Corp. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,583 in reported general payments places this provider in the 75th percentile of 97 pain medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pain medicine in Shreveport
- Prathima AnandiShreveport$19K
- Raju BeharaShreveport$9K
- Sudarshan TangaShreveport$4K
- Varsha AllampalliShreveport$3K
- Thomas MyersMandeville$118K
- Alan KayeNew Orleans$76K
- Derrick DeanTerrytown$68K
- Hazem EissaNew Orleans$50K
- Robert OwensNew Orleans$47K
- Gassan ChaibanLake Charles$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.